← Eichor
Condition: Epilepsy Generalized Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Epilepsy Generalized

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT07675746A Safety and Efficacy of Intrathecally Administered ION283 in Patients With Lafora Disease
Phase 1/Phase 2 · 1 location(s) · Berge Minassian · NCT06609889Etiology and Treatment of Neonatal Seizure
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT03822741A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
Phase 3 · 58 location(s) · Stoke Therapeutics, Inc · NCT06872125An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Phase 2 · 11 location(s) · Praxis Precision Medicines · NCT06908356Characterization by Automated System on Infantile Spasmes
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06266234Study of Transcranial Direct Current Stimulation to Treat Epilepsy
NA · 1 location(s) · Mayo Clinic · NCT05673915Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
NA · 1 location(s) · Mayo Clinic · NCT07012148LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
Phase 3 · 5 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT07234695Treatment of Refractory Infantile Spasms With Fenfluramine
Phase 2 · 2 location(s) · Children's Hospital of Orange County · NCT04289467Ketogenic Diet for New-Onset Absence Epilepsy
Phase 3 · 1 location(s) · Johns Hopkins University · NCT04274179Registry and Natural History Study for Progressive Myoclonus Epilepsy Type 1 (EPM1)
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06593951Idiopathic Generalized Epilepsy Cognitive and Emotional Profile
Phase N/A · 1 location(s) · IRCCS National Neurological Institute "C. Mondino" Foundatio · NCT06782074Biology of Juvenile Myoclonic Epilepsy
Phase N/A · 15 location(s) · King's College London · NCT03400371ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Phase 1/Phase 2 · 3 location(s) · Ionis Pharmaceuticals, Inc. · NCT07531745Global Registry and Natural History Study for Mitochondrial Disorders
Phase N/A · 33 location(s) · LMU Klinikum · NCT05554835Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05420935North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)
Phase N/A · 17 location(s) · Columbia University · NCT01694940A Study to Prevent Infantile Spasms Relapse
Phase 2 · 1 location(s) · University of California, Los Angeles · NCT06819670Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Vigabatrin With High Dose Prednisolone Combination Therapy vs Vigabatrin Alone for Infantile Spasm
NA · 1 location(s) · Kullasate Sakpichaisakul · NCT04302116Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
Phase 4 · 1 location(s) · University of Colorado, Denver · NCT06598449A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Phase 3 · 138 location(s) · Xenon Pharmaceuticals Inc. · NCT05667142SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom
Phase N/A · 1 location(s) · NHS Greater Glasgow and Clyde · NCT06504511Electroclinical Correlation of Anxiety
NA · 1 location(s) · University Hospital, Bordeaux · NCT05393518Idiopathic Generalized Epilepsy Syndromes
Phase N/A · 1 location(s) · Shen Chun-Hong · NCT06388174ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.
Phase 3 · 25 location(s) · Ono Pharmaceutical Co., Ltd. · NCT06579573A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndro
Phase 1/Phase 2 · 14 location(s) · Encoded Therapeutics · NCT05419492A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Phase 3 · 102 location(s) · Longboard Pharmaceuticals · NCT06660394Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07251673
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.